{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:14:13Z","timestamp":1777011253461,"version":"3.51.4"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mild Cognitive Impairment (MCI) is a neurological condition characterized by a noticeable decline in cognitive abilities that falls between normal aging and dementia. Along with some biomarkers like GAP-43, A\u03b2, tau, and P-tau, brain activity and connectivity are ascribed to MCI; however, the link between brain connectivity changes and such biomarkers in MCI is still being investigated. This study explores the relationship between biomarkers like GAP-43, A\u03b2, tau, and P-tau, and brain connectivity. We enrolled 25 Participants with normal cognitive function and 23 patients with MCI. Levels of GAP-43, A\u03b21\u201342, t-tau, and p-tau181p in the CSF were measured, and functional connectivity measures including ROI-to-voxel (RV) correlations and the DMN RV-ratio were extracted from the resting-state fMRI data. <jats:italic>P<\/jats:italic>-values below 0.05 were considered significant. The results showed that in CN individuals, higher connectivity within the both anterior default mode network (aDMN) and posterior DMN (pDMN) was associated with higher levels of the biomarker GAP-43. In contrast, MCI individuals showed significant negative correlations between DMN connectivity and levels of tau and P-tau. Notably, no significant correlations were found between A\u03b2 levels and connectivity measures in either group. These findings suggest that elevated levels of GAP-43 indicate increased functional connectivity in aDMN and pDMN. Conversely, elevated levels of tau and p-tau can disrupt connectivity through various mechanisms. Thus, the accumulation of tau and p-tau can lead to impaired neuronal connectivity, contributing to cognitive decline.<\/jats:p>","DOI":"10.1186\/s13041-024-01136-z","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:02:43Z","timestamp":1725001363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-\u03b2 measurements: a resting-state fMRI study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0351-7876","authenticated-orcid":false,"given":"Mohammad","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-9419","authenticated-orcid":false,"given":"Ali","family":"Azargoonjahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamide","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Yaghoobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Saeideh","family":"Chavoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilan","family":"Baghaeikia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Mahzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arina","family":"Valipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Razeghi Oskouei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Shahkarami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4656-156X","authenticated-orcid":false,"given":"Mahsa","family":"Mayeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"1136_CR1","doi-asserted-by":"publisher","unstructured":"Bai W, Chen P, Cai H, Zhang Q, Su Z, Cheung T, et al. Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age Ageing. 2022;51(8). https:\/\/doi.org\/10.1093\/ageing\/afac173.","DOI":"10.1093\/ageing\/afac173"},{"issue":"12","key":"1136_CR2","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985\u201392. https:\/\/doi.org\/10.1001\/archneur.58.12.1985.","journal-title":"Arch Neurol"},{"issue":"2","key":"1136_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1017\/s1041610204000092","volume":"16","author":"M Bruscoli","year":"2004","unstructured":"Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr. 2004;16(2):129\u201340. https:\/\/doi.org\/10.1017\/s1041610204000092.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1136_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s1474-4422(03)00262-x","volume":"2","author":"C DeCarli","year":"2003","unstructured":"DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2003;2(1):15\u201321. https:\/\/doi.org\/10.1016\/s1474-4422(03)00262-x.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1136_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/archneurol.2009.106","volume":"66","author":"ST Farias","year":"2009","unstructured":"Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol. 2009;66(9):1151\u20137. https:\/\/doi.org\/10.1001\/archneurol.2009.106.","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"1136_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.08.026","volume":"312","author":"M Guo","year":"2012","unstructured":"Guo M, Gao L, Zhang G, Li Y, Xu S, Wang Z, et al. Prevalence of dementia and mild cognitive impairment in the elderly living in nursing and veteran care homes in Xi\u2019an, China. J Neurol Sci. 2012;312(1\u20132):39\u201344. https:\/\/doi.org\/10.1016\/j.jns.2011.08.026.","journal-title":"J Neurol Sci"},{"key":"1136_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1192\/bjp.bp.105.014779","volume":"189","author":"A Busse","year":"2006","unstructured":"Busse A, Angermeyer MC, Riedel-Heller SG. Progression of mild cognitive impairment to dementia: a challenge to current thinking. Br J Psychiatry. 2006;189:399\u2013404. https:\/\/doi.org\/10.1192\/bjp.bp.105.014779.","journal-title":"Br J Psychiatry"},{"key":"1136_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnagi.2020.00077","volume":"12","author":"W Lin","year":"2020","unstructured":"Lin W, Gao Q, Yuan J, Chen Z, Feng C, Chen W, et al. Predicting Alzheimer\u2019s Disease Conversion from mild cognitive impairment using an Extreme Learning Machine-based Grading Method with Multimodal Data. Front Aging Neurosci. 2020;12:77. https:\/\/doi.org\/10.3389\/fnagi.2020.00077.","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"1136_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrneurol.2010.170","volume":"6","author":"N Jones","year":"2010","unstructured":"Jones N. Biomarkers predict conversion from MCI to AD. Nat Reviews Neurol. 2010;6(12):646. https:\/\/doi.org\/10.1038\/nrneurol.2010.170.","journal-title":"Nat Reviews Neurol"},{"key":"1136_CR10","doi-asserted-by":"publisher","first-page":"103533","DOI":"10.1016\/j.nicl.2023.103533","volume":"40","author":"O Crystal","year":"2023","unstructured":"Crystal O, Maralani PJ, Black S, Fischer C, Moody AR, Khademi A. Detecting conversion from mild cognitive impairment to Alzheimer\u2019s disease using FLAIR MRI biomarkers. NeuroImage: Clin. 2023;40:103533. https:\/\/doi.org\/10.1016\/j.nicl.2023.103533.","journal-title":"NeuroImage: Clin"},{"issue":"4","key":"1136_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/157015906778520782","volume":"4","author":"JB Denny","year":"2006","unstructured":"Denny JB. Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43. Curr Neuropharmacol. 2006;4(4):293\u2013304. https:\/\/doi.org\/10.2174\/157015906778520782.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1136_CR12","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1212\/wnl.0000000000201417","volume":"100","author":"A \u00d6hrfelt","year":"2023","unstructured":"\u00d6hrfelt A, Benedet AL, Ashton NJ, Kvartsberg H, Vandijck M, Weiner MW, et al. Association of CSF GAP-43 with the rate of Cognitive decline and progression to dementia in amyloid-positive individuals. Neurology. 2023;100(3):e275\u201385. https:\/\/doi.org\/10.1212\/wnl.0000000000201417.","journal-title":"Neurology"},{"key":"1136_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010013","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Guo X, Zhu F, Zhang Q, Yang Y. For the Alzheimer\u2019s Disease Neuroimaging I. Association of CSF GAP-43 and APOE \u03b54 with cognition in mild cognitive impairment and Alzheimer\u2019s Disease. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12010013.","journal-title":"Cells"},{"issue":"21","key":"1136_CR14","doi-asserted-by":"publisher","first-page":"e2065","DOI":"10.1212\/wnl.0000000000012853","volume":"97","author":"M Mil\u00e0-Alom\u00e0","year":"2021","unstructured":"Mil\u00e0-Alom\u00e0 M, Brinkmalm A, Ashton NJ, Kvartsberg H, Shekari M, Operto G, et al. CSF synaptic biomarkers in the preclinical stage of Alzheimer Disease and their Association with MRI and PET: a cross-sectional study. Neurology. 2021;97(21):e2065\u201378. https:\/\/doi.org\/10.1212\/wnl.0000000000012853.","journal-title":"Neurology"},{"key":"1136_CR15","doi-asserted-by":"publisher","unstructured":"Lu Y. Cerebrospinal fluid growth-associated protein 43 levels in patients with progressive and stable mild cognitive impairment. Aging Clin Exp Res. 2022;34. https:\/\/doi.org\/10.1007\/s40520-022-02202-z.","DOI":"10.1007\/s40520-022-02202-z"},{"issue":"7","key":"1136_CR16","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/acn3.51402","volume":"8","author":"S Bergstr\u00f6m","year":"2021","unstructured":"Bergstr\u00f6m S, Remnest\u00e5l J, Yousef J, Olofsson J, Markaki I, Carvalho S, et al. Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2021;8(7):1456\u201370. https:\/\/doi.org\/10.1002\/acn3.51402.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1136_CR17","doi-asserted-by":"publisher","first-page":"17392","DOI":"10.1038\/s41598-022-20324-2","volume":"12","author":"Q Qiang","year":"2022","unstructured":"Qiang Q, Skudder-Hill L, Toyota T, Wei W, Adachi H. CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer\u2019s disease. Sci Rep. 2022;12(1):17392. https:\/\/doi.org\/10.1038\/s41598-022-20324-2.","journal-title":"Sci Rep"},{"issue":"1","key":"1136_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","volume":"15","author":"\u00c5 Sandelius","year":"2019","unstructured":"Sandelius \u00c5, Portelius E, K\u00e4ll\u00e9n \u00c5, Zetterberg H, Rot U, Olsson B, et al. Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with tau and amyloid pathology. Alzheimer\u2019s Dement. 2019;15(1):55\u201364. https:\/\/doi.org\/10.1016\/j.jalz.2018.08.006.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1136_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12021-024-09663-9","author":"H Seyedmirzaei","year":"2024","unstructured":"Seyedmirzaei H, Salmannezhad A, Ashayeri H, Shushtari A, Farazinia B, Heidari MM, et al. Growth-Associated protein 43 and Tensor-based morphometry indices in mild cognitive impairment. Neuroinformatics. 2024. https:\/\/doi.org\/10.1007\/s12021-024-09663-9.","journal-title":"Neuroinformatics"},{"issue":"1","key":"1136_CR20","doi-asserted-by":"publisher","first-page":"13984","DOI":"10.1038\/s41598-019-50315-9","volume":"9","author":"TB Chen","year":"2019","unstructured":"Chen TB, Lee YJ, Lin SY, Chen JP, Hu CJ, Wang PN, Cheng IH. Plasma A\u03b242 and total tau predict Cognitive decline in amnestic mild cognitive impairment. Sci Rep. 2019;9(1):13984. https:\/\/doi.org\/10.1038\/s41598-019-50315-9.","journal-title":"Sci Rep"},{"issue":"5","key":"1136_CR21","doi-asserted-by":"publisher","first-page":"e26839","DOI":"10.1016\/j.heliyon.2024.e26839","volume":"10","author":"J Tang","year":"2024","unstructured":"Tang J, Chen Q, Fu Z, Liang Y, Xu G, Zhou H, He B. Interaction between A\u03b2 and tau on reversion and conversion in mild cognitive impairment patients: after 2-year follow-up. Heliyon. 2024;10(5):e26839. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26839.","journal-title":"Heliyon"},{"issue":"2","key":"1136_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neurobiolaging.2005.01.011","volume":"27","author":"RB Maccioni","year":"2006","unstructured":"Maccioni RB, Lavados M, Guill\u00f3n M, Mujica C, Bosch R, Far\u00edas G, Fuentes P. Anomalously phosphorylated tau and A\u03b2 fragments in the CSF correlates with cognitive impairment in MCI subjects. Neurobiol Aging. 2006;27(2):237\u201344. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.01.011.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1136_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13195-024-01455-2","volume":"16","author":"Z Husz\u00e1r","year":"2024","unstructured":"Husz\u00e1r Z, Engh MA, Pavlekovics M, Sato T, Steenkamp Y, Hanseeuw B, et al. Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis. Alzheimers Res Ther. 2024;16(1):81. https:\/\/doi.org\/10.1186\/s13195-024-01455-2.","journal-title":"Alzheimers Res Ther"},{"key":"1136_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1041610213001087","volume":"25","author":"K Harrington","year":"2013","unstructured":"Harrington K, Lim YY, Ellis K, Copolov C, Darby D, Weinborn M, et al. The association of A\u03b2 amyloid and composite cognitive measures in healthy older adults and MCI. Int Psychogeriatr. 2013;25:1\u201311. https:\/\/doi.org\/10.1017\/S1041610213001087.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"1136_CR25","doi-asserted-by":"publisher","first-page":"fcac016","DOI":"10.1093\/braincomms\/fcac016","volume":"4","author":"DA Stevens","year":"2022","unstructured":"Stevens DA, Workman CI, Kuwabara H, Butters MA, Savonenko A, Nassery N, et al. Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment. Brain Commun. 2022;4(1):fcac016. https:\/\/doi.org\/10.1093\/braincomms\/fcac016.","journal-title":"Brain Commun"},{"issue":"1","key":"1136_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nrleng.2011.03.007","volume":"27","author":"JA Monge-Argil\u00e9s","year":"2012","unstructured":"Monge-Argil\u00e9s JA, S\u00e1nchez-Pay\u00e1 J, Mu\u00f1oz-Ruiz C, Pampliega-P\u00e9rez A, G\u00f3mez-L\u00f3pez MJ, Rodr\u00edguez Borja E, et al. Patients with mild cognitive impairment and a reduced CSF A\u03b21\u201342 protein progress rapidly to Alzheimer\u2019s disease. Neurolog\u00eda (English Edition). 2012;27(1):28\u201333. https:\/\/doi.org\/10.1016\/j.nrleng.2011.03.007.","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"1136_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-12-420071-5.00003-X","volume-title":"Cognitive neuroscience and psychotherapy","author":"WW Tryon","year":"2014","unstructured":"Tryon WW. Chapter 3 - Core Network principles: the explanatory nucleus. In: Tryon WW, editor. Cognitive neuroscience and psychotherapy. San Diego: Academic; 2014. pp. 125\u2013222."},{"key":"1136_CR28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fnins.2018.00770","volume":"12","author":"M Grieder","year":"2018","unstructured":"Grieder M, Wang DJJ, Dierks T, Wahlund LO, Jann K. Default Mode Network Complexity and Cognitive decline in mild Alzheimer\u2019s Disease. Front Neurosci. 2018;12:770. https:\/\/doi.org\/10.3389\/fnins.2018.00770.","journal-title":"Front Neurosci"},{"key":"1136_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neubiorev.2008.09.002","volume":"33","author":"S Broyd","year":"2008","unstructured":"Broyd S, Demanuele C, Debener S, Helps S, James C, Sonuga-Barke E. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev. 2008;33:279\u201396. https:\/\/doi.org\/10.1016\/j.neubiorev.2008.09.002.","journal-title":"Neurosci Biobehav Rev"},{"key":"1136_CR30","doi-asserted-by":"publisher","first-page":"812664","DOI":"10.3389\/fnagi.2022.812664","volume":"14","author":"Y Luo","year":"2022","unstructured":"Luo Y, Qiao M, Liang Y, Chen C, Zeng L, Wang L, Wu W. Functional brain connectivity in mild cognitive impairment with Sleep disorders: a study based on resting-state functional magnetic resonance imaging. Front Aging Neurosci. 2022;14:812664. https:\/\/doi.org\/10.3389\/fnagi.2022.812664.","journal-title":"Front Aging Neurosci"},{"key":"1136_CR31","doi-asserted-by":"publisher","first-page":"1037347","DOI":"10.3389\/fnagi.2022.1037347","volume":"14","author":"L Penalba-S\u00e1nchez","year":"2022","unstructured":"Penalba-S\u00e1nchez L, Oliveira-Silva P, Sumich AL, Cifre I. Increased functional connectivity patterns in mild Alzheimer\u2019s disease: a rsfMRI study. Front Aging Neurosci. 2022;14:1037347. https:\/\/doi.org\/10.3389\/fnagi.2022.1037347.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"1136_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922\u201335.","journal-title":"J Am Geriatr Soc"},{"key":"1136_CR33","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez I, Smailagic N, i Figuls MR, Ciapponi A, Sanchez\u2010Perez E, Giannakou A et al. Mini\u2010Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane database of systematic reviews. 2015(3).","DOI":"10.1002\/14651858.CD010783.pub2"},{"key":"1136_CR34","doi-asserted-by":"crossref","unstructured":"Mitchell AJ. The Mini-mental State Examination (MMSE): update on its diagnostic accuracy and clinical utility for cognitive disorders. Cogn Screen Instruments: Practical Approach. 2017:37\u201348.","DOI":"10.1007\/978-3-319-44775-9_3"},{"issue":"2","key":"1136_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, et al. Simultaneous measurement of beta-amyloid(1\u201342), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2005;51(2):336\u201345. https:\/\/doi.org\/10.1373\/clinchem.2004.039347.","journal-title":"Clin Chem"},{"key":"1136_CR36","volume-title":"Biomarkers for early diagnosis of Alzheimer\u2019s disease","author":"H Vanderstichele","year":"2008","unstructured":"Vanderstichele H, De Meyer G, Shapiro F, Engelborghs S, De Deyn P, Shaw L, Trojanowski J. Biomarkers for early diagnosis of Alzheimer\u2019s disease. Hauppauge, NY: Nova Science; 2008."},{"issue":"11","key":"1136_CR37","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1523\/jneurosci.09-11-03861.1989","volume":"9","author":"TG Gorgels","year":"1989","unstructured":"Gorgels TG, Van Lookeren Campagne M, Oestreicher AB, Gribnau AA, Gispen WH. B-50\/GAP43 is localized at the cytoplasmic side of the plasma membrane in developing and adult rat pyramidal tract. J Neurosci. 1989;9(11):3861\u20139. https:\/\/doi.org\/10.1523\/jneurosci.09-11-03861.1989.","journal-title":"J Neurosci"},{"issue":"13","key":"1136_CR38","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1016\/S0021-9258(19)50388-X","volume":"267","author":"SA Spencer","year":"1992","unstructured":"Spencer SA, Schuh SM, Liu WS, Willard MB. GAP-43, a protein associated with axon growth, is phosphorylated at three sites in cultured neurons and rat brain. J Biol Chem. 1992;267(13):9059\u201364.","journal-title":"J Biol Chem"},{"issue":"5","key":"1136_CR39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/cbf.2914","volume":"31","author":"S Morita","year":"2013","unstructured":"Morita S, Miyata S. Synaptic localization of growth-associated protein 43 in cultured hippocampal neurons during synaptogenesis. Cell Biochem Funct. 2013;31(5):400\u201311. https:\/\/doi.org\/10.1002\/cbf.2914.","journal-title":"Cell Biochem Funct"},{"issue":"13","key":"1136_CR40","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.1073\/pnas.97.13.7657","volume":"97","author":"A Routtenberg","year":"2000","unstructured":"Routtenberg A, Cantallops I, Zaffuto S, Serrano P, Namgung U. Enhanced learning after genetic overexpression of a brain growth protein. Proc Natl Acad Sci U S A. 2000;97(13):7657\u201362. https:\/\/doi.org\/10.1073\/pnas.97.13.7657.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1136_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0092-8674(95)90168-x","volume":"83","author":"L Aigner","year":"1995","unstructured":"Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, et al. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell. 1995;83(2):269\u201378. https:\/\/doi.org\/10.1016\/0092-8674(95)90168-x.","journal-title":"Cell"},{"issue":"26","key":"1136_CR42","doi-asserted-by":"publisher","first-page":"10824","DOI":"10.1073\/pnas.1219256110","volume":"110","author":"AL Allegra Mascaro","year":"2013","unstructured":"Allegra Mascaro AL, Cesare P, Sacconi L, Grasselli G, Mandolesi G, Maco B, et al. In vivo single branch axotomy induces GAP-43-dependent sprouting and synaptic remodeling in cerebellar cortex. Proc Natl Acad Sci U S A. 2013;110(26):10824\u20139. https:\/\/doi.org\/10.1073\/pnas.1219256110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1136_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fncel.2017.00266","volume":"11","author":"MR Holahan","year":"2017","unstructured":"Holahan MR. A shift from a pivotal to supporting role for the Growth-Associated Protein (GAP-43) in the coordination of Axonal Structural and functional plasticity. Front Cell Neurosci. 2017;11:266. https:\/\/doi.org\/10.3389\/fncel.2017.00266.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1136_CR44","doi-asserted-by":"publisher","first-page":"17702","DOI":"10.1038\/s41598-017-17377-z","volume":"7","author":"AD Nemes","year":"2017","unstructured":"Nemes AD, Ayasoufi K, Ying Z, Zhou QG, Suh H, Najm IM. Growth Associated protein 43 (GAP-43) as a Novel Target for the diagnosis, Treatment and Prevention of Epileptogenesis. Sci Rep. 2017;7(1):17702. https:\/\/doi.org\/10.1038\/s41598-017-17377-z.","journal-title":"Sci Rep"},{"key":"1136_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2015.04.042","volume":"597","author":"D Gorup","year":"2015","unstructured":"Gorup D, Boha\u010dek I, Mili\u010devi\u0107 T, Pochet R, Mitre\u010di\u0107 D, Kri\u017e J, Gajovi\u0107 S. Increased expression and colocalization of GAP43 and CASP3 after brain ischemic lesion in mouse. Neurosci Lett. 2015;597:176\u201382. https:\/\/doi.org\/10.1016\/j.neulet.2015.04.042.","journal-title":"Neurosci Lett"},{"issue":"2","key":"1136_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0304-3940(98)00712-5","volume":"255","author":"CE Hulsebosch","year":"1998","unstructured":"Hulsebosch CE, DeWitt DS, Jenkins LW, Prough DS. Traumatic brain injury in rats results in increased expression of Gap-43 that correlates with behavioral recovery. Neurosci Lett. 1998;255(2):83\u20136. https:\/\/doi.org\/10.1016\/s0304-3940(98)00712-5.","journal-title":"Neurosci Lett"},{"issue":"6","key":"1136_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/bf00296492","volume":"88","author":"K Yamada","year":"1994","unstructured":"Yamada K, Goto S, Oyama T, Inoue N, Nagahiro S, Ushio Y. In vivo induction of the growth associated protein GAP43\/B-50 in rat astrocytes following transient middle cerebral artery occlusion. Acta Neuropathol. 1994;88(6):553\u20137. https:\/\/doi.org\/10.1007\/bf00296492.","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"1136_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0304-3940(93)90557-2","volume":"162","author":"RP Stroemer","year":"1993","unstructured":"Stroemer RP, Kent TA, Hulsebosch CE. Acute increase in expression of growth associated protein GAP-43 following cortical ischemia in rat. Neurosci Lett. 1993;162(1\u20132):51\u20134. https:\/\/doi.org\/10.1016\/0304-3940(93)90557-2.","journal-title":"Neurosci Lett"},{"issue":"2","key":"1136_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0006-8993(94)91332-3","volume":"647","author":"S Goto","year":"1994","unstructured":"Goto S, Yamada K, Inoue N, Nagahiro S, Ushio Y. Increased expression of growth-associated protein GAP-43\/B-50 following cerebral hemitransection or striatal ischemic injury in the substantia nigra of adult rats. Brain Res. 1994;647(2):333\u20139. https:\/\/doi.org\/10.1016\/0006-8993(94)91332-3.","journal-title":"Brain Res"},{"issue":"9","key":"1136_CR50","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1161\/01.STR.29.9.1972","volume":"29","author":"Y Li","year":"1998","unstructured":"Li Y, Jiang N, Powers C, Chopp M. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke. 1998;29(9):1972\u201381.","journal-title":"Stroke"},{"key":"1136_CR51","doi-asserted-by":"publisher","unstructured":"Mil\u00e0 Alom\u00e0 M, Brinkmalm A, Ashton N, Kvartsberg H, Shekari M, Operto G, et al. CSF synaptic biomarkers in the preclinical stage of Alzheimer Disease and their Association with MRI and PET: a cross-sectional study. Neurology. 2021;97. https:\/\/doi.org\/10.1212\/WNL.0000000000012853.","DOI":"10.1212\/WNL.0000000000012853"},{"issue":"1","key":"1136_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","volume":"15","author":"\u00c5 Sandelius","year":"2019","unstructured":"Sandelius \u00c5, Portelius E, K\u00e4ll\u00e9n \u00c5, Zetterberg H, Rot U, Olsson B, et al. Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with tau and amyloid pathology. Alzheimers Dement. 2019;15(1):55\u201364. https:\/\/doi.org\/10.1016\/j.jalz.2018.08.006.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1136_CR53","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/prca.201500150","volume":"10","author":"J Remnest\u00e5l","year":"2016","unstructured":"Remnest\u00e5l J, Just D, Mitsios N, Fredolini C, Mulder J, Schwenk JM, et al. CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer\u2019s disease. Proteom Clin Appl. 2016;10(12):1242\u201353. https:\/\/doi.org\/10.1002\/prca.201500150.","journal-title":"Proteom Clin Appl"},{"issue":"4","key":"1136_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000051268","volume":"12","author":"M Sj\u00f6gren","year":"2001","unstructured":"Sj\u00f6gren M, Davidsson P, Gottfries J, Vanderstichele H, Edman A, Vanmechelen E, et al. The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer\u2019s disease, reflecting a common pathophysiological process. Dement Geriatr Cogn Disord. 2001;12(4):257\u201364. https:\/\/doi.org\/10.1159\/000051268.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"1136_CR55","doi-asserted-by":"publisher","first-page":"e953","DOI":"10.1212\/wnl.0000000000010131","volume":"95","author":"M Tible","year":"2020","unstructured":"Tible M, Sandelius \u00c5, H\u00f6glund K, Brinkmalm A, Cognat E, Dumurgier J, et al. Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease. Neurology. 2020;95(8):e953\u201361. https:\/\/doi.org\/10.1212\/wnl.0000000000010131.","journal-title":"Neurology"},{"issue":"S5","key":"1136_CR56","doi-asserted-by":"publisher","first-page":"e044098","DOI":"10.1002\/alz.044098","volume":"16","author":"K Dhiman","year":"2020","unstructured":"Dhiman K, Villemagne VLL, Eratne D, Graham PL, Fowler CJ, Bourgeat P, et al. Elevated levels of synaptic protein GAP-43 associate with brain tauopathy, atrophy and cognition in Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2020;16(S5):e044098. https:\/\/doi.org\/10.1002\/alz.044098.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"1136_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41467-023-44374-w","volume":"15","author":"N Franzmeier","year":"2024","unstructured":"Franzmeier N, Dehsarvi A, Steward A, Biel D, Dewenter A, Roemer SN, et al. Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer\u2019s disease. Nat Commun. 2024;15(1):202. https:\/\/doi.org\/10.1038\/s41467-023-44374-w.","journal-title":"Nat Commun"},{"key":"1136_CR58","doi-asserted-by":"publisher","unstructured":"Seyedmirzaei H, Salmannezhad A, Ashayeri H, Shushtari A, Farazinia B, Heidari MM et al. Growth-Associated Protein 43 and Tensor-Based Morphometry Indices in Mild Cognitive Impairment. Neuroinformatics. 2024:1\u201312. https:\/\/doi.org\/10.1007\/s12021-024-09663-9","DOI":"10.1007\/s12021-024-09663-9"},{"issue":"5","key":"1136_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/neu.480230506","volume":"23","author":"SM Strittmatter","year":"1992","unstructured":"Strittmatter SM, Vartanian T, Fishman MC. GAP-43 as a plasticity protein in neuronal form and repair. J Neurobiol. 1992;23(5):507\u201320.","journal-title":"J Neurobiol"},{"key":"1136_CR60","doi-asserted-by":"crossref","unstructured":"Holahan MR. GAP-43 in synaptic plasticity: molecular perspectives. Research and Reports in Biochemistry. 2015:137\u2009\u2013\u200946.","DOI":"10.2147\/RRBC.S73846"},{"issue":"6","key":"1136_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1101\/lm.581907","volume":"14","author":"MR Holahan","year":"2007","unstructured":"Holahan MR, Honegger KS, Tabatadze N, Routtenberg A. GAP-43 gene expression regulates information storage. Learn Mem. 2007;14(6):407\u201315.","journal-title":"Learn Mem"},{"key":"1136_CR62","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fnhum.2014.00074","volume":"8","author":"W Li","year":"2014","unstructured":"Li W, Mai X, Liu C. The default mode network and social understanding of others: what do brain connectivity studies tell us. Front Hum Neurosci. 2014;8:74. https:\/\/doi.org\/10.3389\/fnhum.2014.00074.","journal-title":"Front Hum Neurosci"},{"key":"1136_CR63","doi-asserted-by":"publisher","unstructured":"Luo W, Liu B, Tang Y, Huang J, Wu J. Rest to promote learning: a brain default Mode Network Perspective. Behav Sci (Basel). 2024;14(4). https:\/\/doi.org\/10.3390\/bs14040349.","DOI":"10.3390\/bs14040349"},{"key":"1136_CR64","doi-asserted-by":"publisher","first-page":"21001","DOI":"10.1038\/srep21001","volume":"6","author":"X Xu","year":"2016","unstructured":"Xu X, Yuan H, Lei X. Activation and connectivity within the default Mode Network Contribute independently to future-oriented thought. Sci Rep. 2016;6:21001. https:\/\/doi.org\/10.1038\/srep21001.","journal-title":"Sci Rep"},{"issue":"1","key":"1136_CR65","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","volume":"8","author":"S Palmqvist","year":"2017","unstructured":"Palmqvist S, Sch\u00f6ll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, et al. Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017;8(1):1214. https:\/\/doi.org\/10.1038\/s41467-017-01150-x.","journal-title":"Nat Commun"},{"issue":"34","key":"1136_CR66","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25(34):7709\u201317.","journal-title":"J Neurosci"},{"issue":"2","key":"1136_CR67","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","volume":"63","author":"RA Sperling","year":"2009","unstructured":"Sperling RA, LaViolette PS, O\u2019Keefe K, O\u2019Brien J, Rentz DM, Pihlajamaki M, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009;63(2):178\u201388.","journal-title":"Neuron"},{"issue":"7","key":"1136_CR68","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/brain\/awu103","volume":"137","author":"N Myers","year":"2014","unstructured":"Myers N, Pasquini L, G\u00f6ttler J, Grimmer T, Koch K, Ortner M, et al. Within-patient correspondence of amyloid-\u03b2 and intrinsic network connectivity in Alzheimer\u2019s disease. Brain. 2014;137(7):2052\u201364.","journal-title":"Brain"},{"issue":"7","key":"1136_CR69","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/brain\/awt146","volume":"136","author":"J Sepulcre","year":"2013","unstructured":"Sepulcre J, Sabuncu MR, Becker A, Sperling R, Johnson KA. In vivo characterization of the early states of the amyloid-beta network. Brain. 2013;136(7):2239\u201352.","journal-title":"Brain"},{"key":"1136_CR70","doi-asserted-by":"publisher","unstructured":"Cheung EYW, Chau ACM, Shea YF, Chiu PKC, Kwan JSK, Mak HKF. Level of Amyloid-\u03b2 (A\u03b2) binding leading to Differential effects on resting state functional connectivity in Major Brain Networks. Biomedicines. 2022;10(9). https:\/\/doi.org\/10.3390\/biomedicines10092321.","DOI":"10.3390\/biomedicines10092321"},{"key":"1136_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.dadm.2016.11.006","volume":"5","author":"R Nuttall","year":"2016","unstructured":"Nuttall R, Pasquini L, Scherr M, Sorg C. Degradation in intrinsic connectivity networks across the Alzheimer\u2019s disease spectrum. Alzheimers Dement (Amst). 2016;5:35\u201342. https:\/\/doi.org\/10.1016\/j.dadm.2016.11.006.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1136_CR72","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1038\/s41598-017-06876-8","volume":"7","author":"A Nakamura","year":"2017","unstructured":"Nakamura A, Cuesta P, Kato T, Arahata Y, Iwata K, Yamagishi M, et al. Early functional network alterations in asymptomatic elders at risk for Alzheimer\u2019s disease. Sci Rep. 2017;7(1):6517. https:\/\/doi.org\/10.1038\/s41598-017-06876-8.","journal-title":"Sci Rep"},{"key":"1136_CR73","doi-asserted-by":"publisher","first-page":"120146","DOI":"10.1016\/j.neuroimage.2023.120146","volume":"275","author":"G Liu","year":"2023","unstructured":"Liu G, Shen C, Qiu A. Amyloid-\u03b2 accumulation in relation to functional connectivity in aging: a longitudinal study. NeuroImage. 2023;275:120146. https:\/\/doi.org\/10.1016\/j.neuroimage.2023.120146.","journal-title":"NeuroImage"},{"issue":"1","key":"1136_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","volume":"58","author":"JR Cirrito","year":"2008","unstructured":"Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron. 2008;58(1):42\u201351. https:\/\/doi.org\/10.1016\/j.neuron.2008.02.003.","journal-title":"Neuron"},{"issue":"6","key":"1136_CR75","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/s0896-6273(03)00124-7","volume":"37","author":"F Kamenetz","year":"2003","unstructured":"Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron. 2003;37(6):925\u201337. https:\/\/doi.org\/10.1016\/s0896-6273(03)00124-7.","journal-title":"Neuron"},{"key":"1136_CR76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2012.10.002","volume":"50","author":"X Li","year":"2013","unstructured":"Li X, Uemura K, Hashimoto T, Nasser-Ghodsi N, Arimon M, Lill CM, et al. Neuronal activity and secreted amyloid \u03b2 lead to altered amyloid \u03b2 precursor protein and presenilin 1 interactions. Neurobiol Dis. 2013;50:127\u201334. https:\/\/doi.org\/10.1016\/j.nbd.2012.10.002.","journal-title":"Neurobiol Dis"},{"issue":"28","key":"1136_CR77","doi-asserted-by":"publisher","first-page":"11606","DOI":"10.1073\/pnas.1221536110","volume":"110","author":"M Lehmann","year":"2013","unstructured":"Lehmann M, Madison CM, Ghosh PM, Seeley WW, Mormino E, Greicius MD, et al. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2013;110(28):11606\u201311. https:\/\/doi.org\/10.1073\/pnas.1221536110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1136_CR78","doi-asserted-by":"publisher","first-page":"721171","DOI":"10.3389\/fnagi.2021.721171","volume":"13","author":"B Li","year":"2021","unstructured":"Li B, Zhang M, Jang I, Ye G, Zhou L, He G, et al. Amyloid-Beta influences Memory via Functional Connectivity during Memory Retrieval in Alzheimer\u2019s Disease. Front Aging Neurosci. 2021;13:721171. https:\/\/doi.org\/10.3389\/fnagi.2021.721171.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1136_CR79","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Therapy. 2023;8(1):267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"1136_CR80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflamm. 2023;20(1):165. https:\/\/doi.org\/10.1186\/s12974-023-02853-3.","journal-title":"J Neuroinflamm"},{"key":"1136_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.niox.2023.03.003","volume":"134\u2013135","author":"A Azargoonjahromi","year":"2023","unstructured":"Azargoonjahromi A. Dual role of nitric oxide in Alzheimer\u2019s disease. Nitric Oxide. 2023;134\u2013135:23\u201337. https:\/\/doi.org\/10.1016\/j.niox.2023.03.003.","journal-title":"Nitric Oxide"},{"key":"1136_CR82","doi-asserted-by":"publisher","first-page":"951128","DOI":"10.3389\/fnins.2022.951128","volume":"16","author":"Q Wang","year":"2022","unstructured":"Wang Q, Xie C. Microglia activation linking amyloid-\u03b2 drive tau spatial propagation in Alzheimer\u2019s disease. Front Neurosci. 2022;16:951128. https:\/\/doi.org\/10.3389\/fnins.2022.951128.","journal-title":"Front Neurosci"},{"issue":"7","key":"1136_CR83","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2023;29(7):1775\u201381. https:\/\/doi.org\/10.1038\/s41591-023-02380-x.","journal-title":"Nat Med"},{"key":"1136_CR84","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer\u2019s Disease and related therapeutic targets. Front Immunol. 2022;13:856376. https:\/\/doi.org\/10.3389\/fimmu.2022.856376.","journal-title":"Front Immunol"},{"issue":"4","key":"1136_CR85","doi-asserted-by":"publisher","first-page":"e92325","DOI":"10.1371\/journal.pone.0092325","volume":"9","author":"SS Choi","year":"2014","unstructured":"Choi SS, Lee HJ, Lim I, Satoh J, Kim SU. Human astrocytes: secretome profiles of cytokines and chemokines. PLoS ONE. 2014;9(4):e92325. https:\/\/doi.org\/10.1371\/journal.pone.0092325.","journal-title":"PLoS ONE"},{"issue":"1","key":"1136_CR86","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41467-022-29552-6","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, et al. Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy. Nat Commun. 2022;13(1):1969. https:\/\/doi.org\/10.1038\/s41467-022-29552-6.","journal-title":"Nat Commun"},{"key":"1136_CR87","doi-asserted-by":"publisher","first-page":"570045","DOI":"10.3389\/fnmol.2020.570045","volume":"13","author":"A Michalicova","year":"2020","unstructured":"Michalicova A, Majerova P, Kovac A. Tau protein and its role in blood-brain barrier dysfunction. Front Mol Neurosci. 2020;13:570045. https:\/\/doi.org\/10.3389\/fnmol.2020.570045.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1136_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener. 2021;10(1):45. https:\/\/doi.org\/10.1186\/s40035-021-00270-1.","journal-title":"Transl Neurodegener"},{"issue":"2","key":"1136_CR89","doi-asserted-by":"publisher","first-page":"fcac055","DOI":"10.1093\/braincomms\/fcac055","volume":"4","author":"D Putcha","year":"2022","unstructured":"Putcha D, Eckbo R, Katsumi Y, Dickerson BC, Touroutoglou A, Collins JA. Tau and the fractionated default mode network in atypical Alzheimer\u2019s disease. Brain Commun. 2022;4(2):fcac055. https:\/\/doi.org\/10.1093\/braincomms\/fcac055.","journal-title":"Brain Commun"},{"key":"1136_CR90","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fnins.2017.00167","volume":"11","author":"O Hansson","year":"2017","unstructured":"Hansson O, Grothe MJ, Strandberg TO, Ohlsson T, H\u00e4gerstr\u00f6m D, J\u00f6gi J, et al. Tau Pathology distribution in Alzheimer\u2019s disease corresponds differentially to cognition-relevant Functional Brain Networks. Front Neurosci. 2017;11:167. https:\/\/doi.org\/10.3389\/fnins.2017.00167.","journal-title":"Front Neurosci"},{"issue":"2","key":"1136_CR91","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/brain\/awx353","volume":"141","author":"MC Hoenig","year":"2018","unstructured":"Hoenig MC, Bischof GN, Seemiller J, Hammes J, Kukolja J, Onur \u00d6A, et al. Networks of tau distribution in Alzheimer\u2019s disease. Brain. 2018;141(2):568\u201381. https:\/\/doi.org\/10.1093\/brain\/awx353.","journal-title":"Brain"},{"key":"1136_CR92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cortex.2017.09.018","volume":"97","author":"DT Jones","year":"2017","unstructured":"Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, et al. Tau, amyloid, and cascading network failure across the Alzheimer\u2019s disease spectrum. Cortex. 2017;97:143\u201359. https:\/\/doi.org\/10.1016\/j.cortex.2017.09.018.","journal-title":"Cortex"},{"issue":"16","key":"1136_CR93","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1523\/jneurosci.3263-16.2017","volume":"37","author":"AP Schultz","year":"2017","unstructured":"Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, et al. Phases of Hyperconnectivity and Hypoconnectivity in the default Mode and Salience Networks track with amyloid and tau in clinically normal individuals. J Neurosci. 2017;37(16):4323\u201331. https:\/\/doi.org\/10.1523\/jneurosci.3263-16.2017.","journal-title":"J Neurosci"},{"issue":"1","key":"1136_CR94","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel JW, Iturria-Medina Y, Strandberg OT, Smith R, Levitis E, Evans AC, Hansson O. Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat Commun. 2020;11(1):2612. https:\/\/doi.org\/10.1038\/s41467-020-15701-2.","journal-title":"Nat Commun"},{"key":"1136_CR95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neurobiolaging.2020.03.009","volume":"92","author":"E Kocagoncu","year":"2020","unstructured":"Kocagoncu E, Quinn A, Firouzian A, Cooper E, Greve A, Gunn R, et al. Tau pathology in early Alzheimer\u2019s disease is linked to selective disruptions in neurophysiological network dynamics. Neurobiol Aging. 2020;92:141\u201352. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.03.009.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1136_CR96","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41467-019-14159-1","volume":"11","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Neitzel J, Rubinski A, Smith R, Strandberg O, Ossenkoppele R, et al. Functional brain architecture is associated with the rate of tau accumulation in Alzheimer\u2019s disease. Nat Commun. 2020;11(1):347. https:\/\/doi.org\/10.1038\/s41467-019-14159-1.","journal-title":"Nat Commun"},{"issue":"37","key":"1136_CR97","doi-asserted-by":"publisher","first-page":"8857","DOI":"10.1523\/jneurosci.1687-17.2017","volume":"37","author":"AS Keller","year":"2017","unstructured":"Keller AS, Christopher L. Distinct phases of tau, amyloid, and functional connectivity in healthy older adults. J Neurosci. 2017;37(37):8857\u20139. https:\/\/doi.org\/10.1523\/jneurosci.1687-17.2017.","journal-title":"J Neurosci"},{"key":"1136_CR98","doi-asserted-by":"publisher","unstructured":"Ju Z, Li Z, Lu J, Jiao F, Lin H, Bao W, et al. In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer\u2019s Disease: A (18)F-Florzolotau Study. Brain Sci. 2022;12(10). https:\/\/doi.org\/10.3390\/brainsci12101355.","DOI":"10.3390\/brainsci12101355"},{"key":"1136_CR99","doi-asserted-by":"publisher","first-page":"110777","DOI":"10.1016\/j.brainresbull.2023.110777","volume":"203","author":"VR Bitra","year":"2023","unstructured":"Bitra VR, Challa SR, Adiukwu PC, Rapaka D. Tau trajectory in Alzheimer\u2019s disease: evidence from the connectome-based computational models. Brain Res Bull. 2023;203:110777. https:\/\/doi.org\/10.1016\/j.brainresbull.2023.110777.","journal-title":"Brain Res Bull"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-024-01136-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-024-01136-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-024-01136-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:03:37Z","timestamp":1725001417000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-024-01136-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1186\/s13041-024-01136-z","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using ADNI data. The ADNIstudy is ethically approved and operated in accordance with the Declaration of Helsinki, 1964.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no competing interest to be declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}